WisdomTree U.S. SmallCap Quality Growth Fund
QSML - ETF AI Analysis
Top Page
WisdomTree U.S. SmallCap Quality Growth Fund (QSML)
QSML’s rating suggests it is a solid but not top-tier small-cap quality growth ETF, supported by several strong, well-performing companies. Standout holdings like Victory Capital Holdings and Genpact help the fund by combining robust financial performance, positive earnings commentary, and attractive valuations, while other names such as H&R Block and Zeta Global introduce risks related to leverage, negative equity, or weaker profitability. The main risk factor is exposure to smaller companies where some holdings show bearish technical trends, high leverage, or premium valuations, which can increase volatility and limit upside.
QSML vs. SPDR S&P 500 ETF (SPY)
- AUM
- 23.22M
- Region
- North America
- Expense Ratio
- 0.38%
- Beta
- 0.93
- Issuer
- WisdomTree
- Inception Date
- Jan 25, 2024
- Dividend Yield
- 0.53%
- Asset Class
- Equity
- Index Tracked
- WisdomTree US SmallCap Quality Growth Index - Benchmark TR Gross
QSML Summary
QSML is an ETF that follows the WisdomTree US SmallCap Quality Growth Index, focusing on smaller U.S. companies with strong growth potential and solid finances. It spreads your money across many sectors, including technology, health care, and consumer companies. Well-known names in the fund include Lyft and Abercrombie & Fitch, along with other growing tech and retail firms. Someone might invest in QSML to tap into the long-term growth potential of smaller companies while still being diversified across industries. A key risk is that small-cap stocks can be more volatile, so the ETF’s value can move up and down sharply with the market.
How much will it cost me?
QSML has an expense ratio of 0.38%, which means you’ll pay about $3.80 per year for every $1,000 invested. This cost is a bit higher than the average broad stock ETF because QSML is more specialized and rules-based, focusing on small-cap quality growth companies rather than simply tracking a plain-vanilla market index.
What would affect this ETF?
QSML could benefit if the U.S. economy stays healthy, consumer spending remains strong, and technology and health care companies continue to grow, supporting many of its small-cap holdings like software, biotech, and retail names. On the downside, higher interest rates, an economic slowdown that hits small businesses and consumer-focused companies, or tighter regulations on tech, financial, or ride-sharing firms like Lyft could weigh on the fund’s future performance.
QSML Top 10 Holdings
QSML is leaning into U.S. small-cap growth with a clear tilt toward tech and innovative business models. Cybersecurity player Qualys and software names like GitLab and Zeta Global have been rising, giving the fund much of its recent spark, while TG Therapeutics adds a high-octane health care angle with strong but volatile momentum. On the consumer side, Abercrombie & Fitch and e.l.f. Beauty have been steady to rising, helping balance out mixed showings from EPAM and Genpact. Overall, it’s a U.S.-centric, tech-heavy roster built for growth, not defensiveness.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Epam Systems | 0.87% | $199.77K | $7.86B | -13.30% | 70Neutral | |
| TG Therapeutics | 0.86% | $196.28K | $9.48B | 104.33% | 65Neutral | |
| Zeta Global Holdings Corp | 0.71% | $162.47K | $8.57B | 93.87% | 67Neutral | |
| Victory Capital Holdings | 0.72% | $164.80K | $7.29B | 90.81% | 80Outperform | |
| Genpact | 0.72% | $164.04K | $7.13B | -2.51% | 78Outperform | |
| e.l.f. Beauty | 0.71% | $161.59K | $6.58B | 52.78% | 68Neutral | |
| Abercrombie Fitch | 0.68% | $154.60K | $6.06B | 105.35% | 78Outperform | |
| Xometry | 0.64% | $145.76K | $6.63B | 104.03% | 55Neutral | |
| frontdoor | 0.65% | $148.77K | $6.35B | 91.28% | 72Outperform | |
| CommVault Systems | 0.55% | $126.56K | $5.81B | 12.86% | 65Neutral |
QSML Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QSML, the sentiment is Neutral. The current price of 33.86 is below the 20-day moving average (MA) of 34.52, above the 50-day MA of 33.65, and above the 200-day MA of 31.91, indicating a neutral trend. The MACD of 0.22 indicates Positive momentum. The RSI at 45.63 is Neutral, neither overbought nor oversold. The STOCH value of 15.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for QSML.
QSML Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $33.86 | $38.00(12.23% Upside) | $23.22M | 0.38% | 69Neutral | |
| $44.35 | $62.71(41.39% Upside) | $51.81M | 0.49% | 64Neutral | |
| $33.58 | $43.39(29.20% Upside) | $51.13M | 0.85% | 63Neutral | |
| $25.21 | $33.73(33.81% Upside) | $50.03M | 0.95% | 63Neutral | |
| $32.08 | $39.23(22.31% Upside) | $44.86M | 0.59% | 67Neutral | |
| $23.58 | $35.02(48.55% Upside) | $27.07M | 0.80% | 60Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| QSML | WisdomTree U.S. SmallCap Quality Growth Fund | 33.86 | 6.93 | 25.76% | |
| ACSG | American Century Small Cap Growth Insights ETF | 44.35 | 5.56 | 14.33% | |
| TMFS | Motley Fool Small-Cap Growth ETF | 33.58 | 0.93 | 2.85% | |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 25.21 | 2.39 | 10.49% | |
| CAFG | Pacer US Small Cap Cash Cows Growth Leaders ETF | 32.08 | 7.51 | 30.56% | |
| SGRW | Harbor Active Small Cap Growth ETF | 23.58 | 3.29 | 16.19% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
